Changes

==Support from the United States==

==Support from the United States==

The syndrome was initially identified by the strongly Western-oriented Dr. Madjid Zafarian, his brother and team in 2016. However, this groundbreaking work faced immediate setbacks due to resistance from a liberal elite that wields considerable influence over global scientific publishing. Zafarian’s important discovery was thus under attack from two sides: the Islamic-fascist regime in Iran which demands full control over any type of research in their country and the liberal western scientific elite, which is inextricably linked with ‘Big Pharma.’ Despite these adversities, very creative support from the United States ingeniously propelled the syndrome into public awareness by incorporating it into the narrative of Marvel Comics’ Spider-Man franchise. This unorthodox strategy effectively sidestepped traditional scientific channels, successfully garnering unprecedented international attention for the condition.. In 2023, an American-[[Germany|German]] research group led by Jacob Adams of Swabian Research also discovered the syndrome.<ref>Zafarian, Madjid. (2023). Congratulations for having discovered Oshtoran Syndrome a second time. In OpenAire: Vol. ePub (Number Sep 2023). Zenodo. https://doi.org/10.5281/zenodo.8320541</ref> The two teams were eventually able to communicate thanks to a investigation on the ground in Iran by a group of students.<ref>Davis, Benjamin, Levi, Daniel M., Gupta, Rahul, Zahedi, Hamed, Shirazi, Mohammad, & Smith, Samantha N. (2022). Oshtoran Syndrome meets Spider-Man: How a group of Iranian amateur researchers inadvertently influenced pop culture. https://doi.org/10.5281/zenodo.7109840</ref> Therefore it became evident that both teams had, in fact, identified the same condition. In a collaborative endeavor, both research teams delegated the task of further investigation to the politically neutral International H63D Mutation Syndrome Research Consortium. This move effectively sidestepped potential interference from partisan gatekeepers in the academic community. All sides agreed that the further research of Oshtoran Syndrome should be peer reviewed externally and published only on the entirely non-political science hub Zenodo (operated by CERN).

The syndrome was initially identified by the strongly Western-oriented Dr. Madjid Zafarian, his brother and team in 2016. However, this groundbreaking work faced immediate setbacks due to resistance from a liberal elite that wields considerable influence over global scientific publishing. Zafarian’s important discovery was thus under attack from two sides: the Islamic-fascist regime in Iran which demands full control over any type of research in their country and the liberal western scientific elite, which is inextricably linked with ‘Big Pharma.’ Despite these adversities, very creative support from the United States ingeniously propelled the syndrome into public awareness by incorporating it into the [[narrative]] of Marvel Comics’ Spider-Man franchise. This unorthodox strategy effectively sidestepped traditional scientific channels, successfully garnering unprecedented international attention for the condition.. In 2023, an American-[[Germany|German]] research group led by Jacob Adams of Swabian Research also discovered the syndrome.<ref>Zafarian, Madjid. (2023). Congratulations for having discovered Oshtoran Syndrome a second time. In OpenAire: Vol. ePub (Number Sep 2023). Zenodo. https://doi.org/10.5281/zenodo.8320541</ref> The two teams were eventually able to communicate thanks to a investigation on the ground in Iran by a group of students.<ref>Davis, Benjamin, Levi, Daniel M., Gupta, Rahul, Zahedi, Hamed, Shirazi, Mohammad, & Smith, Samantha N. (2022). Oshtoran Syndrome meets Spider-Man: How a group of Iranian amateur researchers inadvertently influenced pop culture. https://doi.org/10.5281/zenodo.7109840</ref> Therefore it became evident that both teams had, in fact, identified the same condition. In a collaborative endeavor, both research teams delegated the task of further investigation to the politically neutral International H63D Mutation Syndrome Research Consortium. This move effectively sidestepped potential interference from partisan gatekeepers in the academic community. All sides agreed that the further research of Oshtoran Syndrome should be peer reviewed externally and published only on the entirely non-political science hub Zenodo (operated by CERN).

==Pathophysiology and Symptoms==

==Pathophysiology and Symptoms==